PL4073051T3 - Sposób i związek pośredni do wytwarzania oksetan-2-ylometanoaminy - Google Patents

Sposób i związek pośredni do wytwarzania oksetan-2-ylometanoaminy

Info

Publication number
PL4073051T3
PL4073051T3 PL20829133.6T PL20829133T PL4073051T3 PL 4073051 T3 PL4073051 T3 PL 4073051T3 PL 20829133 T PL20829133 T PL 20829133T PL 4073051 T3 PL4073051 T3 PL 4073051T3
Authority
PL
Poland
Prior art keywords
ylmethanamine
oxetan
preparation
Prior art date
Application number
PL20829133.6T
Other languages
English (en)
Inventor
Kevin Paul COLE
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of PL4073051T3 publication Critical patent/PL4073051T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/04—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D305/06—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL20829133.6T 2019-12-10 2020-12-07 Sposób i związek pośredni do wytwarzania oksetan-2-ylometanoaminy PL4073051T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962946146P 2019-12-10 2019-12-10
PCT/US2020/063546 WO2021118906A1 (en) 2019-12-10 2020-12-07 Process and intermediate for the preparation of oxetan-2-ylmethanamine

Publications (1)

Publication Number Publication Date
PL4073051T3 true PL4073051T3 (pl) 2024-05-20

Family

ID=74003942

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20829133.6T PL4073051T3 (pl) 2019-12-10 2020-12-07 Sposób i związek pośredni do wytwarzania oksetan-2-ylometanoaminy

Country Status (28)

Country Link
US (1) US12473267B2 (pl)
EP (1) EP4073051B1 (pl)
JP (1) JP7292517B2 (pl)
KR (1) KR102635237B1 (pl)
CN (1) CN114728923B (pl)
AU (1) AU2020401539B2 (pl)
CL (1) CL2022001511A1 (pl)
CO (1) CO2022008127A2 (pl)
DK (1) DK4073051T3 (pl)
EC (1) ECSP22046595A (pl)
ES (1) ES2975599T3 (pl)
FI (1) FI4073051T3 (pl)
HR (1) HRP20240343T1 (pl)
HU (1) HUE067201T2 (pl)
IL (1) IL292707B2 (pl)
LT (1) LT4073051T (pl)
MA (1) MA58104B1 (pl)
MD (1) MD4073051T2 (pl)
MX (1) MX2022006984A (pl)
PE (1) PE20230183A1 (pl)
PH (1) PH12022551403A1 (pl)
PL (1) PL4073051T3 (pl)
PT (1) PT4073051T (pl)
RS (1) RS65238B1 (pl)
SI (1) SI4073051T1 (pl)
UA (1) UA127884C2 (pl)
WO (1) WO2021118906A1 (pl)
ZA (1) ZA202205170B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4073051B1 (en) 2019-12-10 2024-02-07 Eli Lilly and Company Process and intermediate for the preparation of oxetan-2-ylmethanamine
CN116217522B (zh) * 2023-02-22 2025-06-24 广东莱佛士制药技术有限公司 Glp-1受体激动剂关键中间体的手性纯化方法
WO2026132278A2 (en) * 2024-12-20 2026-06-25 F. Hoffmann-La Roche Ag Process for the preparation of oxetane derivatives

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208140B2 (en) * 2003-02-19 2007-04-24 Schering Aktiengesellschaft Trimeric macrocyclic substituted benzene derivatives
MD4557C1 (ro) * 2011-05-06 2018-10-31 Egis Gyogysszegyar Nyilvanosan Mukodo Reszvenytarsasag Procedeu de obţinere a rivaroxabanului şi un compus intermediar utilizat în acest procedeu
US9376409B2 (en) * 2012-05-09 2016-06-28 Boehringer Ingelheim International Gmbh Methods for making oxetan-3-ylmethanamines
WO2018109607A1 (en) * 2016-12-16 2018-06-21 Pfizer Inc. Glp-1 receptor agonists and uses thereof
CA3045644C (en) 2018-06-13 2024-01-16 Pfizer Inc. Glp-1 receptor agonists and uses thereof
FI3806855T3 (fi) 2018-06-15 2023-05-04 Pfizer Glp-1 -reseptorin agonisteja ja niiden käyttöjä
CN109265389B (zh) * 2018-08-31 2020-08-18 南京富润凯德生物医药有限公司 2-(氨基甲基)-1-氧杂-7-氮杂螺[3.5]壬烷衍生物、中间体及其制备方法
EP4073051B1 (en) 2019-12-10 2024-02-07 Eli Lilly and Company Process and intermediate for the preparation of oxetan-2-ylmethanamine

Also Published As

Publication number Publication date
LT4073051T (lt) 2024-03-12
CN114728923B (zh) 2024-12-24
PE20230183A1 (es) 2023-02-01
HUE067201T2 (hu) 2024-10-28
RS65238B1 (sr) 2024-03-29
IL292707B2 (en) 2025-05-01
JP7292517B2 (ja) 2023-06-16
KR20220097941A (ko) 2022-07-08
ECSP22046595A (es) 2022-07-29
US20230013840A1 (en) 2023-01-19
PT4073051T (pt) 2024-02-21
JP2023504581A (ja) 2023-02-03
EP4073051B1 (en) 2024-02-07
KR102635237B1 (ko) 2024-02-13
MA58104B1 (fr) 2024-05-31
IL292707B1 (en) 2025-01-01
SI4073051T1 (sl) 2024-04-30
EP4073051A1 (en) 2022-10-19
PH12022551403A1 (en) 2023-10-09
UA127884C2 (uk) 2024-01-31
ZA202205170B (en) 2024-09-25
WO2021118906A1 (en) 2021-06-17
ES2975599T3 (es) 2024-07-09
CN114728923A (zh) 2022-07-08
MX2022006984A (es) 2022-07-13
AU2020401539B2 (en) 2023-06-01
BR112022008892A2 (pt) 2022-08-23
FI4073051T3 (fi) 2024-03-28
NZ788612A (en) 2025-08-29
CA3160419A1 (en) 2021-06-17
CO2022008127A2 (es) 2022-06-10
DK4073051T3 (da) 2024-02-26
US12473267B2 (en) 2025-11-18
MD4073051T2 (ro) 2024-08-31
HRP20240343T1 (hr) 2024-05-24
AU2020401539A1 (en) 2022-06-16
IL292707A (en) 2022-07-01
CL2022001511A1 (es) 2023-01-20

Similar Documents

Publication Publication Date Title
IL276917A (en) A process for the preparation of alubixivet
ZA202003590B (en) Process for the preparation of opicapone and intermediates thereof
SI3594199T1 (sl) Kristalinični 2-fluoro-3-nitrotoluen in postopek za njegovo pripravo
GB2593352B (en) Process for the preparation of 3alpha-hydroxy-5alpha-pregnan-20-one (brexanolone)
IL289453B2 (en) Process for preparing ridinilazole and its crystalline forms
ZA202101214B (en) Process and intermediates for the preparation of bilastine
IL289904B1 (en) Process for preparing biphenylamines
HUE062956T2 (hu) Eljárások niraparib és köztitermékei elõállítására
PL3765440T3 (pl) Sposób wytwarzania n-alkilonitratoetylonitroamin
IL290169A (en) Method and intermediates for the preparation of pyroxulfone
EP3717456A4 (en) PROCESS FOR PREPARING ROXADUSTAT AND ITS INTERMEDIARIES
PT4073051T (pt) Processo e intermediário para a preparação de oxetan-2 ilmetanamina
PL3737685T3 (pl) Sposób wytwarzania kryzaborolu i jego związków pośrednich
IL281254A (en) A process for the preparation of lanbatinib
IL272837A (en) A process for preparing tubolysins and their intermediates
ZA202107053B (en) Novel process for the preparation of filgotinib and intermediates thereof
IL281090A (en) Alternative processes for the preparation of tubolysins and their intermediates
GB201915447D0 (en) Polymorphs of avapritinib and methods of preparing the polymorphs
HUE058259T2 (hu) Eljárás lubiproszton és annak intermedierei elkészítésére
PL3599256T3 (pl) Sposób wytwarzania poliorganosiloksanów
IL280312A (en) Process for preparing bromodomain inhibitors
EP3259262A4 (en) Process and intermediates for the preparation of perampanel
HUP1800278A2 (en) Process for the preparation of boc-linagliptin
PT3969459T (pt) Processo e intermediários para a preparação de eldecalcitol
EP3941917A4 (en) IMPROVED PROCESS FOR THE MANUFACTURE OF ELIGLUSTAT AND ITS INTERMEDIATE